Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,146

Nonalcoholic Steatohepatitis

Sheka, A. C., Adeyi, O. A., Thompson, J., Hameed, B., Crawford, P. A., & Ikramuddin, S. (2020) · JAMA · doi:10.1001/jama.2020.2298 · Cited by 1,432

Introduction to Meta-Analysis

Borenstein, M., Hedges, L. V., Higgins, J. P. T., Rothstein, H. R., & Den, A. B. V. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.121 · Cited by 1,260

The Effect of Mediterranean Diet on Metabolic Syndrome and its Components

Kastorini, C.-M., Milionis, H. J., Esposito, K., Giugliano, D., Goudevenos, J. A., & Panagiotakos, D. B. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.073 · Cited by 1,087

Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials

Dinu, M., Pagliai, G., Casini, A., & Sofi, F. (2018) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.58 · Cited by 1,016

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies

Stefan, N., Häring, H., & Cusi, K. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 874

AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667

EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 545

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)

Li, R., Zou, J., Ran, W., Qi, X., Chen, Y., Cui, H., & Guo, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1087260 · Cited by 347

Lifestyle interventions in nonalcoholic fatty liver disease

Younossi, Z. M., Zelber-Sagi, S., Henry, L., & Gerber, L. H. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00800-4 · Cited by 281

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023

ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Cusi, K. J., Hilliard, M. E., Isaacs, D. M., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s004 · Cited by 242

The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis

Haigh, L., Kirk, C., El Gendy, K., Gallacher, J., Errington, L., Mathers, J. C., & Anstee, Q. M. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.06.037 · Cited by 209

The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease

Eslam, M., Fan, J., Yu, M., Wong, V. W., Cua, I. H., Liu, C., Tanwandee, T., Gani, R. A., Seto, W., Alam, S., et al. (2025) · Hepatology International · doi:10.1007/s12072-024-10774-3 · Cited by 200

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2024

ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Cusi, K. J., Ekhlaspour, L., Fleming, T. K., Hilliard, M. E., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc24-s004 · Cited by 173

Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease

Mellemkjær, A., Kjær, M. B., Haldrup, D., Grønbæk, H., & Thomsen, K. L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.11.012 · Cited by 110

Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials

Del Bo’, C., Perna, S., Allehdan, S., Rafique, A., Saad, S., AlGhareeb, F., Rondanelli, M., Tayyem, R. F., Marino, M., Martini, D., et al. (2023) · Nutrients · doi:10.3390/nu15102250 · Cited by 80

Fatty liver index (FLI): more than a marker of hepatic steatosis

Kaneva, A. M., & Bojko, E. R. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00991-z · Cited by 62

MASLD treatment—a shift in the paradigm is imminent

Machado, M. V. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1316284 · Cited by 51

Resmetirom: The First Food and Drug Administration–Approved Medication for Nonalcoholic Steatohepatitis (NASH)

Guirguis, E. H., Dougherty, J., Thornby, K., Grace, Y., & Mack, K. (2024) · Annals of Pharmacotherapy · doi:10.1177/10600280241259528 · Cited by 52

Impact of Dietary Fiber on Inflammation in Humans

Kabisch, S., Hajir, J., Sukhobaevskaia, V., Weickert, M. O., & Pfeiffer, A. F. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052000 · Cited by 54

Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!

Katsiki, N., Stoian, A. P., & Rizzo, M. (2022) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.10.001 · Cited by 40

Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review

Kamada, Y., Takahashi, H., Shimizu, M., Kawaguchi, T., Sumida, Y., Fujii, H., Seko, Y., Fukunishi, S., Tokushige, K., Nakajima, A., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01833-9 · Cited by 43

High Meat Consumption Is Prospectively Associated with the Risk of Non-Alcoholic Fatty Liver Disease and Presumed Significant Fibrosis

Wajcman, D. I., Isakov, N. F., Grinshpan, L. S., Salomone, F., Lazarus, J. V., Webb, M., Shibolet, O., Kariv, R., & Zelber‐Sagi, S. (2022) · Nutrients · doi:10.3390/nu14173533 · Cited by 39

Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease

Xiao, Y., Zhang, X., Yi, D., Qiu, F., Wu, L., Tang, Y., & Wang, N. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1225946 · Cited by 37

Different Dietary Approaches, Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A Literature Review

Torres-Peña, J. D., Larriva, A. P. A.-D., Alcala-Diaz, J. F., López‐Miranda, J., & Delgado‐Lista, J. (2023) · Nutrients · doi:10.3390/nu15061483 · Cited by 40

Personalizing Nutrition Strategies: Bridging Research and Public Health

Clemente‐Suárez, V. J., Peris-Ramos, H. C., Redondo-Flórez, L., Beltrán-Velasco, A. I., Martín-Rodríguez, A., David-Fernandez, S., Sepulveda, R. A. Y., & Tornero-Aguilera, J. F. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14030305 · Cited by 38

Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial

Abad, J., Llop, E., Arias-Loste, M. T., Burgos-Santamaría, D., Martínez Porras, J. L., Iruzubieta, P., Graus, J., Ruiz-Antorán, B., Sánchez Yuste, M. R., Romero-Gómez, M., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.10.027 · Cited by 35

A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease

Ivancovsky Wajcman, D., Byrne, C. J., Dillon, J. F., Brennan, P. N., Villota-Rivas, M., Younossi, Z. M., Allen, A. M., Crespo, J., Gerber, L. H., & Lazarus, J. V. (2026) · Hepatology · doi:10.1097/hep.0000000000001058 · Cited by 33

Nutrition as Therapy in Liver Disease.

Shah, N., & Barritt, A. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.04.012 · Cited by 24

Role of lifestyle and glucagon‐like peptide‐1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases

Giannakogeorgou, A., & Roden, M. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17848 · Cited by 30

Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention

Romero‐Gómez, M., Zelber‐Sagi, S., Martı́n, F., Bugianesi, E., & Soria, B. (2023) · BMJ · doi:10.1136/bmj-2023-075179 · Cited by 29

A healthy lifestyle is prospectively associated with lower onset of metabolic dysfunction–associated steatotic liver disease

Grinshpan, L. S., Haim, Y. E., Wajcman, D. I., Isakov, N. F., Nov, Y., Webb, M., Shibolet, O., Kariv, R., & Zelber‐Sagi, S. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000583 · Cited by 27

Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: Pathophysiology, diagnosis, and emerging therapeutic strategies

Suresh, M. G., Mohamed, S., Geetha, H. S., Prabhu, S., Trivedi, N., Ng, Z. C., Mehta, P. D., Brar, A. S., Sohal, A., Goyal, M. K., et al. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i2.113149 · Cited by 30

Dietary Antioxidants and Natural Compounds in Preventing Thrombosis and Cardiovascular Disease

Giurranna, E., Nencini, F., Bettiol, A., Borghi, S., Argento, F. R., Emmi, G., Silvestri, E., Taddei, N., Fiorillo, C., & Becatti, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111457 · Cited by 30

Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management

Rinella, M. E., & Sookoian, S. C. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01187-8 · Cited by 31

Resistance exercise in combination with aerobic exercise reduces the incidence of serious events in patients with liver cirrhosis: a meta-analysis of randomized controlled trials

Kawaguchi, T., Kawaguchi, A., Hashida, R., Nakano, D., Tsutsumi, T., Kawaguchi, M., Koya, S., Hirota, K., Tomita, M., Tsuchihashi, J., et al. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02060-0 · Cited by 27

Efficacy of the Mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents: a systematic review and meta-analysis

Jamil, A., Chivese, T., Elshaikh, U. A. M., & Sendall, M. C. (2024) · BMC Public Health · doi:10.1186/s12889-024-19378-w · Cited by 26

HFpEF and MASLD: converging mechanisms and clinical implications

Capone, F., Häseli, S. P., Liu, L., Strocchi, S., Langenberg, C., Lusis, A. J., Pietzner, M., Muoio, D. M., Rider, O. J., Raman, B., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01257-z · Cited by 35

Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus—From Prevalence to Diagnostic Approach and Treatment Strategies

Diaconu, C.-T., & Guja, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175144 · Cited by 29

Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!

Katsiki, N., Stoian, A. P., & Rizzo, M. (2022) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2022.07.002 · Cited by 22

Role of MASLD in CVD: A review of emerging treatment options

Mollace, R., Longo, S., Nardin, M., Tavernese, A., Musolino, V., Cardamone, A., & Federici, M. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111891 · Cited by 25

Management of metabolic dysfunction–associated steatotic liver disease ( MASLD )—An expert consensus statement from Indian diabetologists' perspective

Zargar, A. H., Bhansali, A. K., Majumder, A., Maheshwari, A., Bhattacharyya, A., Dasgupta, A., Saboo, B., Sethi, B. K., Sanyal, D., Seshadri, K., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16496 · Cited by 25

Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?

Seidita, A., Cusimano, A., Giuliano, A., Meli, M., Carroccio, A., Soresi, M., & Giannitrapani, L. (2024) · Antioxidants · doi:10.3390/antiox13060731 · Cited by 21

Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength

Crișan, D., Avram, L., Morariu-Barb, A. M., Grapa, C. M., Hirişcău, E. I., Crăciun, R., Donca, V., & Nemeș, A. (2025) · Nutrients · doi:10.3390/nu17010178 · Cited by 21

From steatosis to cirrhosis: the role of obesity in the progression of liver disease

Nowak, K., Paluch, M., Cudzik, M., Syska, K., Gawlikowska, W., & Janczura, J. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01754-x · Cited by 20

Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease

Hao, X., Song, H., Su, X. Y., Li, J., Ye, Y., Wang, C., Xu, X. D., Pang, G., Liu, W., Li, Z., et al. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2464223 · Cited by 18

Nutritional and Lifestyle Therapy for NAFLD in People with HIV

Cinque, F., Cespiati, A., Lombardi, R., Guaraldi, G., & Sebastiani, G. (2023) · Nutrients · doi:10.3390/nu15081990 · Cited by 19

Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics

Pandey, H., Goel, P., Srinivasan, V. M., Tang, D. W. T., Wong, S. H., & Lal, D. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i6.106849 · Cited by 20

Endocrinologist's crucial role in metabolic dysfunction-associated steatotic liver disease: a comprehensive review

Reytor-González, C., Annunziata, G., Campuzano-Donoso, M., Morales-López, T., Basantes-Tituaña, C., Fascì-Spurio, F., Verde, L., Muscogiuri, G., Barrea, L., Frías-Toral, E., et al. (2025) · Minerva Endocrinology · doi:10.23736/s2724-6507.24.04314-8 · Cited by 15

Approach to the Patient With Nonalcoholic Fatty Liver Disease

Belfort‐DeAguiar, R., Lomonaco, R., & Cusi, K. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac624 · Cited by 16

Mediterranean diet and associated metabolite signatures in relation to MASLD progression: A prospective cohort study

Wang, K., Xiang, S., He, Q., Liu, A., Huang, C., Yang, Z. Y., Li, R., Hu, J., Cai, R., Mi, N., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000791 · Cited by 14

The Mediterranean Diet, the DASH Diet, and the MIND Diet in Relation to Sleep Duration and Quality: A Narrative Review

Różańska, D. (2024) · Nutrients · doi:10.3390/nu16234191 · Cited by 14

Adherence to the Mediterranean diet to prevent or delay hepatic steatosis: a longitudinal analysis within the PREDIMED study

Cueto-Galán, R., Fontalba-Navas, A., Gutiérrez‐Bedmar, M., Ruiz‐Canela, M., Martínez‐González, M. Á., Alves, L., Babió, N., Fitó, M., Ros, E., Fiol, M., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1518082 · Cited by 15

Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

Bernhard, J., Galli, L., Speidl, W. S., & Krychtiuk, K. A. (2025) · Current Cardiology Reports · doi:10.1007/s11886-024-02185-5 · Cited by 18

Metabolic-Associated Steatotic Liver Disease (MASLD) and Type 2 Diabetes: Mechanisms, Diagnostic Approaches, and Therapeutic Interventions

Ntikoudi, A., Papachristou, A., Tsalkitzi, A., Margari, N., Evangelou, E., & Vlachou, E. D. (2025) · Diabetology · doi:10.3390/diabetology6040023 · Cited by 14

Non-invasive assessment of liver fibrosis in MASLD: the need of sex-adjusted scores

Novielli, F., Matteis, C. D., Moschetta, A., & Crudele, L. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2557243 · Cited by 13

The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Tsamos, G., Kalopitas, G., Evripidou, K., Vasdeki, D., Koufakis, T., Kanavas, V., Antza, C., Germanidis, G. S., & Chourdakis, M. (2024) · Nutrients · doi:10.3390/nu16060857 · Cited by 11

High Compliance to Mediterranean Diet Associates with Lower Platelet Activation and Liver Collagen Deposition in Patients with Nonalcoholic Fatty Liver Disease

Baratta, F., Cammisotto, V., Tozzi, G., Coronati, M., Bartimoccia, S., Castellani, V., Nocella, C., D’Amico, A., Angelico, F., Carnevale, R., et al. (2022) · Nutrients · doi:10.3390/nu14061209 · Cited by 10

Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department

Miano, N., Todaro, G., Marco, M. D., Scilletta, S., Bosco, G., Barbagallo, F. D. G., Scicali, R., Piro, S., Purrello, F., & Pino, A. D. (2024) · Nutrients · doi:10.3390/nu16121925 · Cited by 10

Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United States

Ruiz‐Casas, L., Pedra, G., Shaikh, A., Franks, B., Dhillon, H. S., Fernandes, J. D. D. R., Mangla, K. K., Augusto, M., Schattenberg, J. M., & Romero‐Gómez, M. (2021) · Medicine · doi:10.1097/md.0000000000028165 · Cited by 10

Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease

Hsieh, M.-L., Su, T., Lin, Y., Chen, Y., Tung, C.-F., Huang, L., Wu, C.-H., Peng, Y., & Hsieh, V. C. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70259 · Cited by 8

High red meat consumption among PNPLA3 polymorphism carriers is associated with NAFLD in a multi-center cross-sectional study

Álvares‐da‐Silva, M. R., Wajcman, D. I., de Oliveira, C. P. M. S., Rabie, S. M. S., Longo, L., Cruz, C. U., Yoshimura, S. M., Joveleviths, D., Ben‐Yehoyada, M., Grinshpan, L. S., et al. (2024) · European Journal of Clinical Nutrition · doi:10.1038/s41430-024-01416-w · Cited by 10

Diet and vascular risk

Gómez-Delgado, F., Romero‐Cabrera, J. L., & Pérez‐Martínez, P. (2022) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000960 · Cited by 8

The impact of dietary interventions on liver health biomarkers in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic literature review and meta-analysis of randomized controlled trials

Stern, U. M., Wagenpfeil, G., Weber, S. N., Alqahtani, S. A., Michel, M. S., & Schattenberg, J. M. (2026) · European Journal of Nutrition · doi:10.1007/s00394-025-03870-z · Cited by 11

What should we advise MAFLD patients to eat and drink?

Machado, M. V. (2021) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2021.11 · Cited by 7

Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026

Akuta, N., Kogiso, T., Ikejima, K., Otsuka, M., Kawaguchi, T., Kawanaka, M., Takahashi, H., Tamaki, N., Nakagawa, H., 疋田隼人, et al. (2026) · Journal of Gastroenterology · doi:10.1007/s00535-026-02408-2 · Cited by 9

Current Treatment Options, Including Diet, Exercise, and Medications

Noureddin, M., & Abdelmalek, M. F. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.008 · Cited by 6

Guía de práctica clínica multidisciplinar de manejo de la esteatosis hepática metabólica

Romero‐Gómez, M., Escalada, J., Noguerol, M., Pérez, A., Carretero, J., Crespo, J., Mascort, J. J., Aguilar, I., Tinahones, F. J., Cañones, P., et al. (2025) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2025.502442 · Cited by 9

The Role of the Mediterranean Diet and Alcohol Consumption in Chronic Liver Disease Prevention: A Narrative Review

Barbería-Latasa, M., Martínez‐Urbistondo, D., & Martínez‐González, M. Á. (2025) · Medicina · doi:10.3390/medicina61101777 · Cited by 5

Inverse associations between Mediterranean diet constituents and the gut microbiota in metabolic-associated steatotic liver disease (MASLD): a case-control study

Williams, G. M., Hoedt, E. C., Duncanson, K., Gan, L. T., Prakoso, E., Talley, N. J., & Beck, E. J. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00939-8 · Cited by 5

Higher diet quality is associated with a lower prevalence of MASLD and adverse health outcomes: insights from NHANES 2005 to 2020

Sualeheen, A., Tan, S., Daly, R. M., Georgousopoulou, E. N., Roberts, S. K., & George, E. S. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03809-4 · Cited by 5

Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease

Shenoy, A., Ahmed, A., & Kim, D. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.73 · Cited by 4

Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management

Brouwer, W. P., Vonghia, L., Thiele, M. S., Schattenberg, J. M., Anastasiou, F., Beckmann, S., Bugianesi, E., Castéra, L., Caussy, C., Cordie, A., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101798 · Cited by 6

Adherence to the Dietary Approaches to Stop Hypertension diet was associated with the risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies

Momeni, S., Hajizadeh‐Sharafabad, F., & Pashaei, M. R. (2025) · Nutrition Research · doi:10.1016/j.nutres.2025.03.005 · Cited by 4

Quelle alimentation proposer aux patients présentant une stéatohépatite non-alcoolique ?

André‐Dumont, S., & Lanthier, N. (2022) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2021.11.001 · Cited by 4

Nutritional and Fasting Strategies for the Management of MASLD / MASH : An Integrative Review

Tawk, D., Ghader, G., Khatib, Y., Attieh, P., Youssef, T., Othman, M., Harb, F., Azar, S. T., & Ghadieh, H. E. (2025) · JGH Open · doi:10.1002/jgh3.70315 · Cited by 3

The effects of nutritional interventions in patients with non-alcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials

Sun, L., Chen, H., Ou, Q., Liang, X., Wu, Q., Yu, X., Zhao, H., Huang, Q., Yi, Z., Tan, X., et al. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.104138 · Cited by 3

The consequences of poor dietary patterns on the proliferation of non-alcoholic fatty liver disease

Ahmed, A., Maham, K., Afzaal, M., Saleem, M. A., Nadeem, M., Saeed, F., Hussain, M., & Jbawi, E. M. A. (2024) · Cogent Food & Agriculture · doi:10.1080/23311932.2024.2325206 · Cited by 4

Dietary Intake of Major Minerals and Trace Elements in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Implications for Dietary Intervention

Va, I., Нисановна, С. А., Morozov, S. V., & Goncharov, A. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03238-z · Cited by 3

Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)

Walczak, P., Walczak, K., Zdun, S., Nemeczek, S., MERKISZ, K., Grzybowski, J., Marciniak, A., Grzywna, N., JASKUŁA, K., & ORŁOWSKI, W. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.13.03.008 · Cited by 3

Association between the Mediterranean dietary pattern and metabolic dysfunction-associated steatotic liver disease: a longitudinal analysis from UK BIOBANK

George, E. S., Sualeheen, A., Freer, C. L., Georgeousopoulou, E. N., Roberts, S. K., Daly, R. M., & Tan, S. (2026) · British Journal Of Nutrition · doi:10.1017/s0007114526107351 · Cited by 2

The role of primary care in response to the global liver disease syndemic: a Lancet Gastroenterology & Hepatology Commission

Jarvis, H., Brennan, P., Casanovas, T., Casler, K., Desai, M., Evans, P. H., Dillon, J. F., Grattagliano, I., Hallsworth, K., Hebditch, V., et al. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(26)00015-4 · Cited by 3

Mediterranean diet and metabolic outcomes in nafld/masld: A systematic review and meta-analysis of randomized controlled trials

Valenzuela‐Fuenzalida, J. J., Salazar-Arancibia, T., Laborie-Reyes, B., Rodriguez-Ortiz, F., Loaiza-Giraldo, J. P., Salgado, C., Nova-Baeza, P., Orellana-Donoso, M., Moya, M. P., Bruna-Mejías, A., et al. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.105017 · Cited by 3

Dietary and nutrition considerations in caring for patients with nonalcoholic fatty liver disease: Updates for the practicing clinician

Newberry, C. A., & Kumar, S. R. (2022) · Nutrition in Clinical Practice · doi:10.1002/ncp.10917 · Cited by 2

Metabolic Dysfunction-Associated Steatotic Liver Disease and Heart Failure with Preserved Ejection Fraction: A Bidirectional Relationship with Clinical and Therapeutic Implications

Leite, A. R., Dias, J., Godinho, T., Correia-Chaves, J., Borges‐Canha, M., Lourenço, I. M., Leite-Moreira, A. F., & Neves, J. S. (2024) · Endocrinology Insights · doi:10.1159/000541442 · Cited by 3

Dietary Patterns Rich in Soybean Products, Vegetables, Fish, Fruits, and Miso Soup Were Inversely Associated with Fatty Liver Index: The Nagahama Study

Yoko, U. E. B. A., Ikeda, K., Tabara, Y., Nakayama, T., Tanaka, D., Takahashi, Y., Kosugi, S., Setoh, K., Kawaguchi, T., Matsuda, F., et al. (2025) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.71.25 · Cited by 2

The Dietary Pattern Concerning Non-alcoholic Fatty Liver: An Umbrella Review and Meta-analyses of Observational Studies and Intervention Trials

Moradi, S., Saber, A., Moradinazar, M., Heydarian, A., Cheshmeh, S., Sadeghi, F., & Pasdar, Y. (2024) · Journal of Kermanshah University of Medical Sciences · doi:10.5812/jkums-142759 · Cited by 1

Quantitative color analysis of the diets of patients with metabolic dysfunction‐associated steatotic liver disease: Comparative study with nutritionally balanced diets

Yamazaki, A., Takachi, Y., Takahashi, H., Hara, N., Ogawa, Y., Hyogo, H., Koseki, M., Hayakawa, M., Nakajima, A., Iwaki, M., et al. (2024) · Hepatology Research · doi:10.1111/hepr.14138 · Cited by 1

Recompensation in Cirrhosis: Biomarkers and Strategies

Ramírez-Quesada, W. E., Alvarado‐Tápias, E., Shalaby, S., & Hernández–Gea, V. (2025) · Seminars in Liver Disease · doi:10.1055/a-2542-9930 · Cited by 1

Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis

Romero‐Gómez, M., Escalada, J., Noguerol, M., Pérez, A., Carretero, J., Crespo, J., Mascort, J. J., Aguilar, I., Tinahones, F. J., Cañones, P., et al. (2025) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2025.502442 · Cited by 1

Hepatocyte nuclear factors dynamically regulate triglyceride metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease: Mechanisms and implications

Li, S., Wu, J., Zhou, Y., Wang, C., Xie, L., Liu, S., Su, Y., He, W., Chen, H., Zhong, W.-W., et al. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i10.109898 · Cited by 1

Systemic lipid remodeling associated with deferoxamine treatment, dietary intervention and combinatorial effect in ameliorating high cholesterol diet-induced steatotic liver in mice

Ni, Z., Wang, R., Miao, H., Wang, G., Lim, W. L. F., Zhang, S., Lam, S. M., & Shui, G. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.02.067 · Cited by 1

Metabolically associated fatty liver disease: What hepatologists need to know about this systemic disease

PLAKIDA, A. L., Юшковська, О., & Sierpińska, L. E. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i3.113284 · Cited by 1

Evaluating the clinical effects of GLP-1 receptor agonists for Alzheimer's and Parkinson's diseases using minimal clinically important difference: systematic review and meta-analysis

Elghanam, Y., & Kim, E. (2026) · Archives of Pharmacal Research · doi:10.1007/s12272-026-01615-y · Cited by 2

Gut microbiota dysbiosis–induced chronic inflammation as a driver of atherosclerosis: cellular crosstalk and host–microbe interactions

Da, S., Gao, H., Wang, T., Wei, Q., Liu, A., & Ren, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1789194 · Cited by 1

Intermittent fasting for the management of NAFLD: Is there enough evidence?

Cernea, S., & Ruţă, F. D. (2023) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2023-0001 · Cited by 1

The Relationship Between the Score of Adherence to the Mediterranean Diet, the Dietary Approaches to Stop Hypertension Diet, the Healthy Eating Index, and the Risk of Non-Alcoholic Fatty Liver Disease in Iranian Adults: A Case-Control Study

Pirabbasi, E., Behbahani, H. B., Salimi, Z., Mansoori, A., Dehghanseresht, N., & Asadi, M. (2023) · Zahedan Journal of Research in Medical Sciences · doi:10.5812/zjrms-138464 · Cited by 1

Metabolite Signatures and Their Mediation Effects on the Relationship Between Mediterranean Diet Adherence and MASLD ProgressionPreprint

Wang, K., Xiang, S., He, Q., Huang, C., Yang, Z. Y., Li, R., Liu, A., Cai, R., Mi, N., Liang, Z., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6026627/v1 · Cited by 1

Corrigendum. Guía de práctica clínica multidisciplinar de manejo de la esteatosis hepática metabólica

Romero-Gómez, M., Escalada, J., Noguerol, M., Pérez, A., Carretero, J., Crespo, J., Mascort, J. J., Aguilar, I., Tinahones, F., Cañones, P., et al. (2026) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2025.502639 · Cited by 1

Epidemiological Evidence – Health Outcomes

Richard Hoffman PhD RNutr, F. R. S. A. (2022) · Wiley eBooks · doi:10.1002/9781119826743.ch4

Tratamiento no farmacológico de la NAFLD/NASH

Rojo, M., & Pérez, J. N. (2023) · Diabetes práctica · doi:10.52102/diabet/pract.esteatosis.art6

Principles of Nutrition in Patients with Non-alcoholic Fatty Liver Disease

Mobasheri, N., Ghahremani, L., & Nazari, M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1008363

RCPE in association with the American College of Gastroenterology and the Scottish Society of Gastroenterology – Gastroenterology: A global perspective

Murray, J., Kefayat, A., Finlayson, M., Seenan, J. P., Hsu, R., & Din, S. (2025) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/14782715251332318

The Role of Mediterranean, DASH, and Vegetarian Diets in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Sustainability and Alignment with SDGs

Alhouei, B., & Doaei, S. (2025) · Food Science and Nutrition Cases · doi:10.1079/fsncases.2025.0014

Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations

Akhlaghi, M., Ghaseminasab-Parizi, M., & Riasatian, M. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00475-2 · Cited by 54

Impact of a Mediterranean diet on hepatic and metabolic outcomes in non‐alcoholic fatty liver disease: The MEDINA randomised controlled trial

George, E. S., Reddy, A., Nicoll, A. J., Ryan, M. C., Itsiopoulos, C., Abbott, G., Johnson, N. A., Sood, S., Roberts, S. K., & Tierney, A. C. (2022) · Liver International · doi:10.1111/liv.15264 · Cited by 76

The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease

Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.012 · Cited by 778

Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance

Baratta, F., Pastori, D., Polimeni, L., Bucci, T., Ceci, F., Calabrese, C. M., Ernesti, I., Pannitteri, G., Violi, F., Angelico, F., et al. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.371 · Cited by 151

The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials

Moosavian, S. P., Arab, A., & Paknahad, Z. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.10.008 · Cited by 56